ClinicalTrials.gov
public full text
Public Domain
A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression
The purpose of this study is to assess the efficacy and safety of olanzapine and fluoxetine compared to placebo and fluoxetine as treatment for treatment-resistant depression (TRD) in Chinese participants.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Prozac Treatment of Major Depression: Discontinuation Study#804024
- Distress Tolerance for Benzodiazepine Discontinuation#868378
- Sertraline Versus Escitalopram in South Asian Participants With Moderate to Severe Major Depressive Disorder#906923
- Escitalopram as a Mood Stabilizer for Bipolar II Disorder#800244
- Optimizing Outcomes of Treatment-Resistant Depression in Older Adults#1009466
Record · ID 849826
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive